Medical devices, healthcare technology and the business of care
PMA SUPPLEMENT · P040038/S048

XACT Carotid Stent System

Abbott Vascular, Inc. · Decision date Dec 9, 2025

FDA DECISIONP040038/S048

What did the FDA approve?

FDA records P040038/S048 as a supplement to PMA P040038, with the supplement type “Normal 180 Day Track No User Fee”. The recorded decision is approval, dated Dec 9, 2025.

FDA approval order statement

approval for a manufacturing site located at Synergy Health AST, SRL, B13.1 Street 4, Avenue 1, Coyol Free Zone, Coyol, Alajuela, 20102, Costa Rica for sterilization.
Regulatory pathway
PMA supplement
Supplement type
Normal 180 Day Track No User Fee
Clinical specialty
Cardiovascular
Decision date
Dec 9, 2025
FDA change category
Location Change - Manufacturer/Sterilizer/Packager/Supplier

FDA source record

Regulatory record facts

Identifier
P040038/S048
Regulatory pathway
PMA supplement
Product code
NIM
Decision code
APPR
Decision date
Dec 9, 2025
Source update
Nov 9, 2026
Original record
Open FDA source record

About this medical device

FDA device category: Stent, carotid.

Product code
NIM
FDA device class
3

Review the original FDA PMA listing for the original approval scope and linked supplements.

FDA decision timeline

  1. P040038/S048 received

    Application receipt date recorded by FDA.

  2. P040038/S049 · Related supplement

    XACT Carotid Stent System

  3. P040038/S050 · Related supplement

    XACT Carotid Stent System (XACT CSS) and XACT Transcarotid Stent System (XACT TSS)

  4. P040038/S048 · FDA decision

    Normal 180 Day Track No User Fee

  5. P040038/S051 · Related supplement

    XACT Carotid Stent System

Timeline entries are records held by MedtechLedger for P040038. View FDA’s full supplement list.

Related devices and submissions

Same PMA: P040038

Product / regulatory recordCompanyPathwayDecision dateSource
Abbott Vascular, Inc.PMA supplementAug 25, 2025FDA
Abbott Vascular, Inc.PMA supplementOct 17, 2025FDA
Abbott Vascular, Inc.PMA supplementMar 20, 2026FDA

Explore the linked device profile

Other records with product code NIM

A shared product code identifies a classification relationship; it does not establish clinical equivalence.

Regulatory context

A PMA supplement records a change to a device with an existing premarket approval. The supplement’s approval applies to the change described in that submission.

Read our guide to FDA clearance and approval · FDA’s explanation of this pathway

Manufacturer intelligence

Abbott Vascular, Inc.

Headquarters
Not reported
Brand website
Not reported
FDA applicant address
3200 Lakeside Dr., Santa Clara, CA, 95054

Sources and methodology

FDA fields and approval-order wording are presented as source information. MedtechLedger explanations are identified separately and describe the scope of the recorded decision. Indications from an original PMA are historical unless confirmed against subsequent labeling and supplements.

How we use FDA records